Tactile Systems Technology Inc
NASDAQ:TCMD
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.13
18.92
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Tactile Systems Technology Inc
Short-Term Investments
Tactile Systems Technology Inc
Short-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
Short-Term Investments
$13.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
||
Becton Dickinson and Co
NYSE:BDX
|
Short-Term Investments
$445m
|
CAGR 3-Years
233%
|
CAGR 5-Years
71%
|
CAGR 10-Years
-7%
|
||
Boston Scientific Corp
NYSE:BSX
|
Short-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Stryker Corp
NYSE:SYK
|
Short-Term Investments
$834m
|
CAGR 3-Years
122%
|
CAGR 5-Years
57%
|
CAGR 10-Years
-13%
|
||
Abbott Laboratories
NYSE:ABT
|
Short-Term Investments
$232m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-16%
|
||
Intuitive Surgical Inc
NASDAQ:ISRG
|
Short-Term Investments
$2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
0%
|
CAGR 10-Years
14%
|
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.
See Also
What is Tactile Systems Technology Inc's Short-Term Investments?
Short-Term Investments
13.6m
USD
Based on the financial report for Jun 30, 2024, Tactile Systems Technology Inc's Short-Term Investments amounts to 13.6m USD.
What is Tactile Systems Technology Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
-12%
Over the last year, the Short-Term Investments growth was 3%. The average annual Short-Term Investments growth rates for Tactile Systems Technology Inc have been 5% over the past three years , -12% over the past five years .